Term
Treatment of Iron Deficiency Anemia |
|
Definition
PO is recommended route (if tolerated)
Response begins in 7-10 days
Hgb will rise about 1 g/dL per week
Re-evaluate if Hgb does NOT ↑ by 2 g/dL in 3 weeks |
|
|
Term
Dosage of Elemental Iron for Treatment
of Iron Deficiency Anemia |
|
Definition
200 mg daily (2 - 3 doses/day)
Take on empty stomach for max absorption
(↑ absorption with vitamin C)
GI AE may prevent patient from taking on empty stomach |
|
|
Term
Types of PO Fe Supplements |
|
Definition
Ferrous Sulfate (Feosol®)
Ferrous Gluconate (Fergon®)
Ferrous Fumarate (Feostat®)
Polysaccharide-iron Complex (Niferex®) |
|
|
Term
Adverse effects of PO Fe Supplementation |
|
Definition
Abdominal pain
Nausea
Dyspepsia/heartburn
Constipation
Dark stools |
|
|
Term
Drug Interactions with PO Fe Supplementation |
|
Definition
Forms bonds (↓ absorption of other meds)
FQs, Tetracyclines, Phenytoin
Separate the interacting drug by 2-4 hours |
|
|
Term
Black Box for PO Fe Supplementation |
|
Definition
Iron toxicity - severe toxicity may occur in overdose, particularly when ingested by children; iron is a leading cause of fatal poisoning in children; store out of children's reach and in child-resistant containers |
|
|
Term
Use of Parenteral Fe Supplementation |
|
Definition
Iron deficiency anemia & unable to tolerate PO Fe or have failed PO Fe therapy (malabsorption) |
|
|
Term
Use of Iron Dextran (InFED) 50 mg/mL |
|
Definition
Given as IV infusion or IM injection
IM injections: Z-track & staining of skin
Black box warning: test dosing for allergic reaction |
|
|
Term
Newer formulations of parenteral Fe supplements |
|
Definition
Approved for anemia associated with CKD
Less adverse effects (allergenicity) but very expensive
Iron sucrose (Venofer)
Sodium ferric gluconate (Ferrlecit) |
|
|
Term
Treatment of vitamin B12 Deficiency |
|
Definition
Vitamin B12 (Cyanocobalmin)
Route: PO, parenteral
PO: Poor absorption
Parenteral: complete absorption (works without intrinsic factor)
- Deep SQ injection, IM injection
- Dosing daily x 1 week, weekly, then monthly for life |
|
|
Term
Intranasal treatment of Vitamin B12 deficiency |
|
Definition
Nascobal - vitamin B12 nasal spray 500 mcg/spray
Dosing & administration - Initial dose is one spray 500 mcg in ONE nostril once weekly |
|
|
Term
Response to treatment of vitamin B12 deficiency |
|
Definition
Neurologic symptoms & megaloblastic cells
begin resolving within a few days & Hgb
levels begin to ↑ after 1 week of therapy |
|
|
Term
Adverse effects to treatment of vitamin B12 deficiency |
|
Definition
Injection: injection site reaction, rash, pruritis
Nasal: rhinitis; nasal irritation |
|
|
Term
Use of PO Treatment of Folic Acid Deficiency |
|
Definition
- Initial dose of 1 mg/day (malabsorption requires ↑ dosages)
- Response - Rapid resolution of symptoms & reticulocytosis
- Hgb begins to rise after about 2 weeks of therapy, do treatment for 2-4 months
|
|
|
Term
Adverse effects and drug interactions of PO Folic Acid
for Folic Acid Deficiency |
|
Definition
AEs: Allergic reactions, flushing, rash
DIs: Phenytoin (↓ phenytoin levels)
Drug-disease interaction: may obscure dx in
pernicious anemia (vitamin B12) |
|
|
Term
Parenteral Treatment of Folic Acid Deficiency |
|
Definition
|
|
Term
Dosing of Erythropoietin Products |
|
Definition
- Titrating schedule based labs & type/severity of anemia
- Hgb at least every 2 weeks with adjustment of dosing
- Patients should also be assessed for Fe deficiency anemia (adequate Fe stores are required)
- Discontinue: Hgb > 12 g/dL & restart if Hgb < 12 g/dL
|
|
|
Term
Use of erythropoietin products for patients with CKD |
|
Definition
Recommended to start CKD patients on treatment in the earlier stages of CKD
Slowed disease progression with initiation of earlier treatment |
|
|